Notably, TLR9 levels were significantly higher in both the epithelial and stromal compartments of prostate cancer compared with benign prostatic hyperplasia, with the most pronounced expression observed in poorly differentiated tumors (22, 44). Here, TLR9 is linked to prostate carcinoma.